Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Case report
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,024 | Dovepress* | 4,745+ | 249 | 4,994 | |
| PubMed Central* | 279 | 69 | 348 | ||
| Totals | 5,024 | 318 | 5,342 | ||
| *Since 10 June 2022 | |||||
View citations on PubMed Central and Google Scholar